Developer docs
API playgroundTry for free, no card

Search company profiles

Xttrium Laboratories

Full company profile

uuid0009y6q

Namestring
Xttrium Laboratories
Legal namestring
Xttrium Laboratories
Websiteurl
xttrium.com
Company typeenum
Private
Founded yearint
1932
Descriptiontext

Xttrium Laboratories is a family-owned, FDA-approved pharmaceutical manufacturer founded in 1932 and headquartered in Mt. Prospect, Illinois. The company specializes in Chlorhexidine Gluconate (CHG) formulations, producing a 0.12% prescription oral rinse, 2% and 4% topical antiseptic scrub solutions under the Dyna-Hex brand, and a 20% CHG solution used as an active pharmaceutical ingredient (API). The company also manufactures generic prescription oral solutions including Lactulose Solution, USP and Amantadine Hydrochloride Oral Solution. Its manufacturing operations are cGMP compliant, and Xttrium owns multiple FDA-approved New Drug Applications covering antiseptic claims including surgical hand scrub, healthcare personnel hand wash, skin wound cleansing, and patient pre-operative skin preparation.

The company's business model spans three revenue streams: branded antiseptic product sales (primarily through medical wholesalers, healthcare distributors, and 14+ major retail drug chains), private label and contract manufacturing services (offering label artwork, filling, packaging, testing, and shipping since 1984), and API supply (20% CHG solution sold across medical, dental, veterinary, cosmetic, and dairy industries). Go-to-market is exclusively direct B2B — no consumer-facing channels are operated. Xttrium's CHG oral rinse is reportedly dispensed by 90% of national and regional pharmacies, and the company manufactures over 150 branded and private label products in total.

Xttrium operates as a privately held, family-controlled enterprise with no disclosed external funding, no public listing, and no parent company. Its competitive position is anchored by regulatory approvals, decades-long relationships with retail pharmacy chains and wholesalers, and its status as the largest supplier of 20% USP Chlorhexidine Gluconate. The customer base is concentrated in U.S. healthcare providers, dental practices, pharmaceutical companies, and retail pharmacies, with no indication of international operations or geographic expansion.

Short descriptiontext

Xttrium Laboratories is a family-owned FDA-approved pharmaceutical manufacturer founded in 1932, specializing in Chlorhexidine Gluconate antiseptic products, generic prescription oral solutions, and contract manufacturing services for U.S. healthcare providers, wholesalers, and retail pharmacies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMount Prospect, United States
HQ citystring
Mount Prospect
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chlorhexidine gluconate manufacturing, topical antiseptic solutions, pharmaceutical contract manufacturing, generic oral rinse, FDA-approved antiseptics
Industry3 codes
PRIMARYHLAHANAE
Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYCRADAOAF
Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose)
SECONDARYIMALAIAH
Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers)
NAICS code3 codes
  • Soap, Cleaning Compound, and Toilet Preparation Manufacturing3256
  • Soap and Cleaning Compound Manufacturing32561
  • Medical Equipment and Supplies Manufacturing3391
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Branded Antiseptic Products
TypeOne Time License
Description

Sale of branded Chlorhexidine Gluconate antiseptic products including oral rinse and scrub solutions to healthcare providers, pharmacies, and medical institutions

xttrium.com
2Private Label/Contract Manufacturing
TypeProfessional Services
Description

Contract manufacturing services for branded and private label products, offering label artwork, filling, packaging, testing, and shipping capabilities for healthcare and retail partners

xttrium.com
3Active Pharmaceutical Ingredients (API)
TypeLicensing Royalties
Description

Supply of 20% Chlorhexidine Gluconate solution as an active pharmaceutical ingredient for use as a preservative and antibacterial/antiseptic agent across multiple industries

xttrium.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Dyna-Hex
Description

Brand name for Chlorhexidine Gluconate antiseptic scrub solutions (2% and 4% concentrations) used for surgical hand scrub, healthcare personnel hand wash, and skin wound cleansing.

xttrium.com
Core offering1 text field

Xttrium Laboratories manufactures Chlorhexidine Gluconate (CHG) antiseptic products at multiple concentrations, including 0.12% prescription oral rinse, 2% and 4% topical antiseptic scrub solutions (Dyna-Hex brand), and 20% CHG as an active pharmaceutical ingredient. The company also produces generic prescription oral solutions (Lactulose Solution, USP and Amantadine Hydrochloride Oral Solution). In addition, Xttrium offers full-service contract manufacturing for branded and private label partners, including label artwork, filling, packaging, testing, and shipping, from its FDA-approved, cGMP-compliant facility in Mt. Prospect, IL.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 90% of national and regional pharmacies dispense Xttrium Brand Generic CHG Oral Rinse
+2 more records
Product overview1 text field

Xttrium Laboratories is a family-owned FDA-approved manufacturer specializing in antiseptic products and generic prescription pharmaceuticals. The company operates as both a branded and private-label contract manufacturer, producing over 150 products. The core product portfolio centers on Chlorhexidine Gluconate (CHG) formulations at various concentrations: 0.12% oral rinse solution (prescription), 2% and 4% topical antiseptic solutions (Dyna-Hex brand), and 20% solution as an active pharmaceutical ingredient (API). The company also manufactures Lactulose Solution and Amantadine Hydrochloride Oral Solution as prescription generics. Manufacturing capabilities include label artwork, filling, packaging, testing, and shipping with cGMP compliant facilities in the Chicagoland area (Mt. Prospect, IL). The products serve healthcare, retail, dental, veterinary, cosmetic, and dairy industries through both branded and private label channels.

Product and service7 records
1Dyna-Hex 2% (Chlorhexidine Gluconate 2% Topical Antiseptic Solution)
CategoryTopical Antiseptic
Description

Chlorhexidine Gluconate 2% topical antiseptic solution sold under the Dyna-Hex brand, used for surgical hand scrub, healthcare personnel hand wash, skin wound and general skin cleansing, and patient pre-operative skin preparation.

2Dyna-Hex 4% (Chlorhexidine Gluconate 4% Topical Antiseptic Solution)
CategoryTopical Antiseptic
Description

Chlorhexidine Gluconate 4% topical antiseptic solution sold under the Dyna-Hex brand, used for surgical hand scrub, healthcare personnel hand wash, skin wound and general skin cleansing, and patient pre-operative skin preparation.

30.12% Chlorhexidine Gluconate Oral Rinse Solution (Xttrium Brand Generic Rx)
CategoryPrescription Oral Rinse
Description

Prescription 0.12% Chlorhexidine Gluconate oral rinse solution used post oral surgery as an infection prevention product, available in unit dose, 4oz, and 16oz packaging sizes.

420% Chlorhexidine Gluconate Solution (API)
CategoryActive Pharmaceutical Ingredient
Description

20% Chlorhexidine Gluconate solution supplied as an active pharmaceutical ingredient (API) for use as a preservative and antibacterial/antiseptic agent across medical, dental, veterinary, cosmetic, and dairy industries.

5Contract Manufacturing Services
CategoryContract Manufacturing Services
Description

Full-service contract manufacturing for branded and private label partners, offering label artwork, filling, packaging, testing, and shipping using FDA-approved and cGMP-compliant facilities.

6Lactulose Solution, USP
CategoryGeneric Prescription Pharmaceutical
Description

Lactulose Solution, USP for oral administration, manufactured as a generic prescription pharmaceutical.

7Amantadine Hydrochloride Oral Solution, USP
CategoryGeneric Prescription Pharmaceutical
Description

Amantadine Hydrochloride Oral Solution, USP prescription medication manufactured as a generic pharmaceutical.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Xttrium manufactures infection prevention products for many large-scale medical wholesalers and distributors, supplying branded and private label generic drug products nationwide.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Contract manufacturing partnerships with healthcare and pharmaceutical companies for CHG-based antiseptic products, utilizing FDA-approved and cGMP compliant facilities.

3Major Retail Drug Chains
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Xttrium supplies branded and private label generic drug products to over 14 major retail drug chains across the United States, with 90% of national and regional pharmacies dispensing their CHG Oral Rinse.

xttrium.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

PDI manufactures chlorhexidine gluconate-based antiseptic products including skin preps, surgical scrubs, and CHG wipes sold to hospitals and dental practices. It is a direct competitor to Xttrium's Dyna-Hex CHG scrub portfolio across healthcare-acquired infection prevention use cases.

TypeDirect peer
Description

Mölnlycke markets Hibiscrub and Hibitane, well-known CHG-based antiseptic solutions for surgical hand scrub, patient pre-operative skin preparation, and wound cleansing. It competes directly with Xttrium's 2%/4% Dyna-Hex and 20% USP CHG offering in healthcare channel sales.

TypeBroad incumbent
Description

BD offers the ChloraPrep and other CHG/isopropyl antiseptic skin preparation products through its BD Medical segment, alongside a much broader portfolio of medical devices, diagnostics, and biosciences. BD is a broad incumbent with overlapping CHG skin-prep claims and hospital sales infrastructure.

TypeBroad incumbent
Description

3M's Health Care division sells surgical skin antiseptics and CHG-based products alongside wound care, oral care, and drug delivery franchises. It is a broad incumbent whose CHG and antiseptic solutions compete with Xttrium's Dyna-Hex franchise while serving much larger end markets.

TypeBroad incumbent
Description

Ecolab's Healthcare and Life Sciences businesses supply antiseptic products, hand hygiene solutions, and disinfectant formulations to hospitals and dental facilities. It overlaps with Xttrium on CHG and broader infection prevention use cases, though Ecolab is a much larger specialty chemicals and services conglomerate.

6STERIS
TypeBroad incumbent
Description

STERIS provides infection prevention and sterilization products, including surface disinfectants, instrument reprocessing, and certain antiseptic chemistries, sold to hospitals and life-science customers. It is a broad incumbent in healthcare infection prevention adjacent to Xttrium's CHG portfolio.

TypeDirect peer
Description

ANI Pharmaceuticals is a U.S. specialty generics manufacturer operating a small set of cGMP facilities, producing oral solutions, injectables, and niche Rx products. It is a direct comparable to Xttrium's specialty oral Rx business (Lactulose, Amantadine) and private-label manufacturing model.

TypeDirect peer
Description

X-GEN is a privately held specialty pharmaceutical manufacturer developing, manufacturing, and distributing generic oral and topical Rx products. It mirrors Xttrium's model of owning ANDAs and serving both branded and private-label channels in dermatology, infectious disease, and adjacent categories.

TypeBroad incumbent
Description

Viatris (formed via Mylan-Upjohn combination) is a large diversified global generics manufacturer with extensive oral solid and oral solution portfolios. It competes with Xttrium as a generic Rx supplier in categories such as chlorhexidine oral rinse and central nervous system oral solutions like amantadine and lactulose.

TypeDirect peer
Description

Cosette Pharmaceuticals is a U.S. specialty generics manufacturer producing prescription oral and topical dermatology products from FDA-inspected facilities, with a strong private-label and contract manufacturing orientation. It is directly comparable to Xttrium's branded + private-label + CDMO model serving pharmacy and institutional customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Xttrium Laboratories

Pharmaceutical Manufacturingxttrium.com

Xttrium Laboratories is a family-owned FDA-approved pharmaceutical manufacturer founded in 1932, specializing in Chlorhexidine Gluconate antiseptic products, generic prescription oral solutions, and contract manufacturing services for U.S. healthcare providers, wholesalers, and retail pharmacies.

What Xttrium Laboratories does

Xttrium Laboratories is a family-owned, FDA-approved pharmaceutical manufacturer founded in 1932 and headquartered in Mt. Prospect, Illinois. The company specializes in Chlorhexidine Gluconate (CHG) formulations, producing a 0.12% prescription oral rinse, 2% and 4% topical antiseptic scrub solutions under the Dyna-Hex brand, and a 20% CHG solution used as an active pharmaceutical ingredient (API). The company also manufactures generic prescription oral solutions including Lactulose Solution, USP and Amantadine Hydrochloride Oral Solution. Its manufacturing operations are cGMP compliant, and Xttrium owns multiple FDA-approved New Drug Applications covering antiseptic claims including surgical hand scrub, healthcare personnel hand wash, skin wound cleansing, and patient pre-operative skin preparation.

The company's business model spans three revenue streams: branded antiseptic product sales (primarily through medical wholesalers, healthcare distributors, and 14+ major retail drug chains), private label and contract manufacturing services (offering label artwork, filling, packaging, testing, and shipping since 1984), and API supply (20% CHG solution sold across medical, dental, veterinary, cosmetic, and dairy industries). Go-to-market is exclusively direct B2B — no consumer-facing channels are operated. Xttrium's CHG oral rinse is reportedly dispensed by 90% of national and regional pharmacies, and the company manufactures over 150 branded and private label products in total.

Xttrium operates as a privately held, family-controlled enterprise with no disclosed external funding, no public listing, and no parent company. Its competitive position is anchored by regulatory approvals, decades-long relationships with retail pharmacy chains and wholesalers, and its status as the largest supplier of 20% USP Chlorhexidine Gluconate. The customer base is concentrated in U.S. healthcare providers, dental practices, pharmaceutical companies, and retail pharmacies, with no indication of international operations or geographic expansion.

Xttrium Laboratories firmographics

Firmographics
Name
Xttrium Laboratories
Legal name
Xttrium Laboratories
Website
https://xttrium.com
Company type
Private
Founded year
1932
Operating status
Operating
Headcount range
101–250 employees
Short description
Xttrium Laboratories is a family-owned FDA-approved pharmaceutical manufacturer founded in 1932, specializing in Chlorhexidine Gluconate antiseptic products, generic prescription oral solutions, and contract manufacturing services for U.S. healthcare providers, wholesalers, and retail pharmacies.
Ownership category
akta.pro rank

Xttrium Laboratories industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256), Soap and Cleaning Compound Manufacturing (32561), Medical Equipment and Supplies Manufacturing (3391)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro industry
PRIMARYHLAHANAE
Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYCRADAOAF
Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose)
SECONDARYIMALAIAH
Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers)

Keywords

  • Chlorhexidine gluconate manufacturing
  • Topical antiseptic solutions
  • Pharmaceutical contract manufacturing
  • Generic oral rinse
  • FDA-approved antiseptics

Where Xttrium Laboratories is headquartered

Location

Headquarters

HQ city
Mount Prospect
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Xttrium Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D

Revenue model

  1. Branded Antiseptic Products: Sale of branded Chlorhexidine Gluconate antiseptic products including oral rinse and scrub solutions to healthcare providers, pharmacies, and medical institutions
  2. Private Label/Contract Manufacturing: Contract manufacturing services for branded and private label products, offering label artwork, filling, packaging, testing, and shipping capabilities for healthcare and retail partners
  3. Active Pharmaceutical Ingredients (API): Supply of 20% Chlorhexidine Gluconate solution as an active pharmaceutical ingredient for use as a preservative and antibacterial/antiseptic agent across multiple industries

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Xttrium Laboratories product offering

Product offering

Core offering

Xttrium Laboratories manufactures Chlorhexidine Gluconate (CHG) antiseptic products at multiple concentrations, including 0.12% prescription oral rinse, 2% and 4% topical antiseptic scrub solutions (Dyna-Hex brand), and 20% CHG as an active pharmaceutical ingredient. The company also produces generic prescription oral solutions (Lactulose Solution, USP and Amantadine Hydrochloride Oral Solution). In addition, Xttrium offers full-service contract manufacturing for branded and private label partners, including label artwork, filling, packaging, testing, and shipping, from its FDA-approved, cGMP-compliant facility in Mt. Prospect, IL.

Product overview

Xttrium Laboratories is a family-owned FDA-approved manufacturer specializing in antiseptic products and generic prescription pharmaceuticals. The company operates as both a branded and private-label contract manufacturer, producing over 150 products. The core product portfolio centers on Chlorhexidine Gluconate (CHG) formulations at various concentrations: 0.12% oral rinse solution (prescription), 2% and 4% topical antiseptic solutions (Dyna-Hex brand), and 20% solution as an active pharmaceutical ingredient (API). The company also manufactures Lactulose Solution and Amantadine Hydrochloride Oral Solution as prescription generics. Manufacturing capabilities include label artwork, filling, packaging, testing, and shipping with cGMP compliant facilities in the Chicagoland area (Mt. Prospect, IL). The products serve healthcare, retail, dental, veterinary, cosmetic, and dairy industries through both branded and private label channels.

Differentiator

Problem solved

Functional benefit

Brands

  • Dyna-Hex: Brand name for Chlorhexidine Gluconate antiseptic scrub solutions (2% and 4% concentrations) used for surgical hand scrub, healthcare personnel hand wash, and skin wound cleansing.

Products and services

  • Dyna-Hex 2% (Chlorhexidine Gluconate 2% Topical Antiseptic Solution) Chlorhexidine Gluconate 2% topical antiseptic solution sold under the Dyna-Hex brand, used for surgical hand scrub, healthcare personnel hand wash, skin wound and general skin cleansing, and patient pre-operative skin preparation.
  • Dyna-Hex 4% (Chlorhexidine Gluconate 4% Topical Antiseptic Solution) Chlorhexidine Gluconate 4% topical antiseptic solution sold under the Dyna-Hex brand, used for surgical hand scrub, healthcare personnel hand wash, skin wound and general skin cleansing, and patient pre-operative skin preparation.
  • 0.12% Chlorhexidine Gluconate Oral Rinse Solution (Xttrium Brand Generic Rx) Prescription 0.12% Chlorhexidine Gluconate oral rinse solution used post oral surgery as an infection prevention product, available in unit dose, 4oz, and 16oz packaging sizes.
  • 20% Chlorhexidine Gluconate Solution (API) 20% Chlorhexidine Gluconate solution supplied as an active pharmaceutical ingredient (API) for use as a preservative and antibacterial/antiseptic agent across medical, dental, veterinary, cosmetic, and dairy industries.
  • Contract Manufacturing Services Full-service contract manufacturing for branded and private label partners, offering label artwork, filling, packaging, testing, and shipping using FDA-approved and cGMP-compliant facilities.
  • Lactulose Solution, USP Lactulose Solution, USP for oral administration, manufactured as a generic prescription pharmaceutical.
  • Amantadine Hydrochloride Oral Solution, USP Amantadine Hydrochloride Oral Solution, USP prescription medication manufactured as a generic pharmaceutical.

Quantifiable outcome

  • 90% of national and regional pharmacies dispense Xttrium Brand Generic CHG Oral Rinse
  • +2 more outcomes

Companies that use Xttrium Laboratories

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Xttrium Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Xttrium Laboratories partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Medical Wholesalers & DistributorscoreChannel Partner/ Reseller/ DistributorXttrium manufactures infection prevention products for many large-scale medical wholesalers and distributors, supplying branded and private label generic drug products nationwide.
  • Healthcare & Pharmaceutical CompaniescoreStrategic or Co-development PartnerContract manufacturing partnerships with healthcare and pharmaceutical companies for CHG-based antiseptic products, utilizing FDA-approved and cGMP compliant facilities.
  • Major Retail Drug ChainscoreChannel Partner/ Reseller/ DistributorXttrium supplies branded and private label generic drug products to over 14 major retail drug chains across the United States, with 90% of national and regional pharmacies dispensing their CHG Oral Rinse.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Xttrium Laboratories competitors and assessment

Company assessment

Direct peers

  • PDI (Professional Disposables International): PDI manufactures chlorhexidine gluconate-based antiseptic products including skin preps, surgical scrubs, and CHG wipes sold to hospitals and dental practices. It is a direct competitor to Xttrium's Dyna-Hex CHG scrub portfolio across healthcare-acquired infection prevention use cases.
  • Mölnlycke Health Care: Mölnlycke markets Hibiscrub and Hibitane, well-known CHG-based antiseptic solutions for surgical hand scrub, patient pre-operative skin preparation, and wound cleansing. It competes directly with Xttrium's 2%/4% Dyna-Hex and 20% USP CHG offering in healthcare channel sales.
  • ANI Pharmaceuticals: ANI Pharmaceuticals is a U.S. specialty generics manufacturer operating a small set of cGMP facilities, producing oral solutions, injectables, and niche Rx products. It is a direct comparable to Xttrium's specialty oral Rx business (Lactulose, Amantadine) and private-label manufacturing model.
  • X-GEN Pharmaceuticals: X-GEN is a privately held specialty pharmaceutical manufacturer developing, manufacturing, and distributing generic oral and topical Rx products. It mirrors Xttrium's model of owning ANDAs and serving both branded and private-label channels in dermatology, infectious disease, and adjacent categories.
  • Cosette Pharmaceuticals: Cosette Pharmaceuticals is a U.S. specialty generics manufacturer producing prescription oral and topical dermatology products from FDA-inspected facilities, with a strong private-label and contract manufacturing orientation. It is directly comparable to Xttrium's branded + private-label + CDMO model serving pharmacy and institutional customers.

Broad incumbents

  • Becton, Dickinson and Company (BD): BD offers the ChloraPrep and other CHG/isopropyl antiseptic skin preparation products through its BD Medical segment, alongside a much broader portfolio of medical devices, diagnostics, and biosciences. BD is a broad incumbent with overlapping CHG skin-prep claims and hospital sales infrastructure.
  • 3M Health Care: 3M's Health Care division sells surgical skin antiseptics and CHG-based products alongside wound care, oral care, and drug delivery franchises. It is a broad incumbent whose CHG and antiseptic solutions compete with Xttrium's Dyna-Hex franchise while serving much larger end markets.
  • Ecolab: Ecolab's Healthcare and Life Sciences businesses supply antiseptic products, hand hygiene solutions, and disinfectant formulations to hospitals and dental facilities. It overlaps with Xttrium on CHG and broader infection prevention use cases, though Ecolab is a much larger specialty chemicals and services conglomerate.
  • STERIS: STERIS provides infection prevention and sterilization products, including surface disinfectants, instrument reprocessing, and certain antiseptic chemistries, sold to hospitals and life-science customers. It is a broad incumbent in healthcare infection prevention adjacent to Xttrium's CHG portfolio.
  • Viatris: Viatris (formed via Mylan-Upjohn combination) is a large diversified global generics manufacturer with extensive oral solid and oral solution portfolios. It competes with Xttrium as a generic Rx supplier in categories such as chlorhexidine oral rinse and central nervous system oral solutions like amantadine and lactulose.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Xttrium Laboratories social profiles

Digital presence

Xttrium Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Xttrium Laboratories leadership team

Management profile

Number of profiles

Xttrium Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Xttrium Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xttrium Laboratories

What does Xttrium Laboratories do?

Xttrium Laboratories manufactures Chlorhexidine Gluconate (CHG) antiseptic products at multiple concentrations, including 0.12% prescription oral rinse, 2% and 4% topical antiseptic scrub solutions (Dyna-Hex brand), and 20% CHG as an active pharmaceutical ingredient. The company also produces generic prescription oral solutions (Lactulose Solution, USP and Amantadine Hydrochloride Oral Solution). In addition, Xttrium offers full-service contract manufacturing for branded and private label partners, including label artwork, filling, packaging, testing, and shipping, from its FDA-approved, cGMP-compliant facility in Mt. Prospect, IL.

Is Xttrium Laboratories a public or private company?

Xttrium Laboratories is a private company. It is classified as family owned and is currently operating.

When was Xttrium Laboratories founded?

Xttrium Laboratories was founded in 1932. It employs 101 to 250 people.

Where is Xttrium Laboratories based?

Xttrium Laboratories is headquartered in Mount Prospect, United States, in the North America region.

How does Xttrium Laboratories make money?

Three revenue lines are on record. Branded Antiseptic Products are the primary driver. The others are private Label/Contract Manufacturing and active Pharmaceutical Ingredients (API).

Who are Xttrium Laboratories's main competitors?

Direct peers on record are PDI (Professional Disposables International), Mölnlycke Health Care, ANI Pharmaceuticals, X-GEN Pharmaceuticals and Cosette Pharmaceuticals. Broad incumbents are Becton, Dickinson and Company (BD), 3M Health Care, Ecolab, STERIS and Viatris.

Does Xttrium Laboratories have an API?

No public API is recorded for Xttrium Laboratories.

What industry is Xttrium Laboratories in?

Xttrium Laboratories's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAHANAE, Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep), with a secondary code of CRADAOAF, Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose). Its NAICS code is 3256 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales